ARS Pharmaceuticals (SPRY) Return on Assets [ROA] (2021 - 2026)
ARS Pharmaceuticals (SPRY) posted Return on Assets [ROA] of -80.54% for Q2 2026, down 62.01 percentage points from -18.52% a year earlier and down 14.73 percentage points from the prior quarter.
Powered by 
Analysis
ARS Pharmaceuticals (SPRY) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, ARS Pharmaceuticals' Return on Assets [ROA] came in at -50.47%, down 53.21 percentage points from FY2024.
- Annual Return on Assets [ROA] shows a four-year change of -41.94 percentage points (FY2021 to FY2025).
- In prior years, ARS Pharmaceuticals' Return on Assets [ROA] was 2.74% in FY2024 (+23.87 pp), -21.13% in FY2023 (-0.41 pp), -20.72% in FY2022 (-12.19 pp) and -8.53% in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Return on Assets [ROA] in data going back to Q1 2021.
- On a year-over-year basis, Return on Assets [ROA] has declined in each of the last three quarters, with an average year-over-year change of -14.40 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q3 2022, with a gain of 31.41 percentage points; the weakest was Q2 2026, with a drop of 62.01 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was -65.80% (Q1 2026), -51.24% (Q4 2025) and -26.46% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | ARS Pharmaceuticals | 357.89 Mn | 219.49 Mn | 27.61 Mn | -79.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -79.83% |
| Jun 30, 2026 | -80.26% |
| Mar 31, 2026 | -64.41% |
| Dec 31, 2025 | -48.94% |
| Sep 30, 2025 | -23.43% |
| Jun 30, 2025 | -14.96% |
| Mar 31, 2025 | -4.56% |
| Dec 31, 2024 | 2.87% |
| Sep 30, 2024 | -22.11% |
| Jun 30, 2024 | -19.93% |
| Mar 31, 2024 | -21.65% |
| Dec 31, 2023 | -22.72% |
| Sep 30, 2023 | -24.36% |
| Jun 30, 2023 | -20.20% |
| Mar 31, 2023 | -15.32% |
| Dec 31, 2022 | -12.41% |
| Sep 30, 2022 | 9.33% |
| Jun 30, 2022 | 3.38% |
| Mar 31, 2022 | -4.18% |
| Dec 31, 2021 | -9.39% |
API Access
ARS Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "SPRY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SPRY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();